Cite
HARVARD Citation
Novak, P. et al. (n.d.). Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet neurology. 16 (2), pp. 123-134. [Online].